WCM
Wealthcare Capital Management Portfolio holdings
AUM $946M
1-Year Return
10.81%
This Quarter Return
-9.13%
1 Year Return
+10.81%
3 Year Return
+31.19%
5 Year Return
+37.28%
10 Year Return
+79.52%
AUM
$743M
AUM Growth
-$96.8M
(-12%)
Cap. Flow
-$21.9M
Cap. Flow
% of AUM
-2.95%
Top 10 Holdings %
Top 10 Hldgs %
94.41%
Holding
708
New
32
Increased
41
Reduced
161
Closed
430
Top Buys
| 1 |
Vanguard Total Stock Market ETF
VTI
|
+$45.1M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$38.1M |
| 3 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$16M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$652K |
| 5 |
iShares MBS ETF
MBB
|
+$537K |
Top Sells
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$75.3M |
| 2 |
Schwab US TIPS ETF
SCHP
|
+$32M |
| 3 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$4.69M |
| 4 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$4.13M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$1.28M |
Sector Composition
| 1 | Technology | 0.14% |
| 2 | Financials | 0.05% |
| 3 | Consumer Staples | 0.05% |
| 4 | Communication Services | 0.05% |
| 5 | Healthcare | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
STMicroelectronics
STM
$24.3B
| $5K | ﹤0.01% |
249
-83
| -25% | -$1.67K |
|
177
Thermo Fisher Scientific
TMO
$179B
| $5K | ﹤0.01% |
19
-14
| -42% | -$3.68K |
|
178
Becton Dickinson
BDX
$53.4B
| $4K | ﹤0.01% |
19
-5
| -21% | -$1.05K |
|
179
Bank of New York Mellon
BK
$75.1B
| $4K | ﹤0.01% |
111
+32
| +41% | +$1.15K |
|
|
CHCT
180
Community Healthcare Trust
CHCT
$438M
| $4K | ﹤0.01% |
+103
| New | +$4K |
|
|
CSR
181
Centerspace
CSR
$963M
| $4K | ﹤0.01% |
+65
| New | +$4K |
|
182
Danaher
DHR
$136B
| $4K | ﹤0.01% |
33
-1,516
| -98% | -$184K |
|
183
Enbridge
ENB
$107B
| $4K | ﹤0.01% |
135
-167
| -55% | -$4.95K |
|
184
Evolus
EOLS
$422M
| $4K | ﹤0.01% |
1,000
| – | – |
|
185
Honeywell
HON
$134B
| $4K | ﹤0.01% |
33
-17
| -34% | -$2.06K |
|
186
Monarch Casino & Resort
MCRI
$1.86B
| $4K | ﹤0.01% |
+136
| New | +$4K |
|
187
Medtronic
MDT
$120B
| $4K | ﹤0.01% |
47
-49
| -51% | -$4.17K |
|
188
S&P Global
SPGI
$166B
| $4K | ﹤0.01% |
18
-3
| -14% | -$667 |
|
189
Toll Brothers
TOL
$13.6B
| $4K | ﹤0.01% |
+205
| New | +$4K |
|
190
Texas Instruments
TXN
$161B
| $4K | ﹤0.01% |
43
-22
| -34% | -$2.05K |
|
191
Weyerhaeuser
WY
$18B
| $4K | ﹤0.01% |
243
+166
| +216% | +$2.73K |
|
192
AbbVie
ABBV
$382B
| $3K | ﹤0.01% |
39
-65
| -63% | -$5K |
|
193
Analog Devices
ADI
$120B
| $3K | ﹤0.01% |
30
+11
| +58% | +$1.1K |
|
194
Applied Materials
AMAT
$138B
| $3K | ﹤0.01% |
58
-13
| -18% | -$672 |
|
195
Amgen
AMGN
$147B
| $3K | ﹤0.01% |
15
-30
| -67% | -$6K |
|
196
Boeing
BA
$163B
| $3K | ﹤0.01% |
22
-18
| -45% | -$2.46K |
|
197
Atlanta Braves Holdings Series B
BATRK
$2.61B
| $3K | ﹤0.01% |
+148
| New | +$3K |
|
198
Boston Scientific
BSX
$147B
| $3K | ﹤0.01% |
99
-1
| -1% | -$30 |
|
199
Citigroup
C
$185B
| $3K | ﹤0.01% |
71
-92
| -56% | -$3.89K |
|
200
Chubb
CB
$109B
| $3K | ﹤0.01% |
26
-14
| -35% | -$1.62K |
|